...
首页> 外文期刊>Microbial drug resistance: MDR : Mechanisms, epidemiology, and disease >Functionalization of ZnO Nanoparticles by Glutamic Acid and Conjugation with Thiosemicarbazide Alters Expression of Efflux Pump Genes in Multiple Drug-Resistant Staphylococcus aureus Strains
【24h】

Functionalization of ZnO Nanoparticles by Glutamic Acid and Conjugation with Thiosemicarbazide Alters Expression of Efflux Pump Genes in Multiple Drug-Resistant Staphylococcus aureus Strains

机译:谷氨酸ZnO纳米粒子的官能化与硫代氧化物的缀合物改变了多重耐药金黄色葡萄球菌菌株中排水泵基因的表达

获取原文
获取原文并翻译 | 示例
           

摘要

Efflux-mediated drug resistance in bacterial strains is regarded as a major cause of drug resistance. In this study, we aimed to evaluate the expression of some major facilitator superfamily class efflux pump genes (EPGs) in the presence of ZnO nanoparticles (NPs) conjugated to thiosemicarbazide (TSC) under amine functionalization by glutamic acid (ZnO@Glu-TSC) as well as ciprofloxacin (CIP) among multiple drug-resistant Staphylococcus aureus. Synthesized NPs were characterized by ultraviolet-visible spectroscopy, X-ray diffraction pattern, and transmission electron microscopy. Antibiogram and ethidium bromide agar cartwheel method were used to determine the efflux-mediated multidrug-resistant phenotype of clinical strains. Then, expression of EPGs, including norA, norB, norC, and tet38 among the strains, exposed to ZnO@Glu-TSC and CIP was evaluated using quantitative real-time PCR (qPCR). According to the results, the strains resistant to CIP showed minimum inhibitory concentration (MIC) values ranging from 256 to 1,024 mu g/mL, while ZnO@Glu-TSC NPs showed MICs from 8 to 256 mu g/mL against bacterial strains, which indicates stronger antibacterial activity of NPs (2-8-fold) compared to CIP. ZnO@Glu-TSC NPs showed a good bacterial inhibitory potential with average inhibition zones of 11, 15, and 20 mm for concentrations of 50, 100, and 150 mu g/mL, respectively. Moreover, simultaneous use of ZnO@Glu-TSC NPs (1/2 MIC) in combination with CIP (1/2 MIC) significantly reduced the expression of norA, norB, norC, and tet38 by 5.4-, 3.8-, 2.1-, and 3.4-fold, respectively, compared to the CIP alone. Therefore, ZnO@Glu-TSC NPs with their potent antimicrobial effects could be used as an antimicrobial agent against S. aureus for preventive and/or therapeutic approaches.
机译:介入介导的细菌菌株的耐药性被认为是耐药性的主要原因。在这项研究中,我们旨在评估一些主要促进剂超家族级级出血泵基因(EPG)在谷氨酸胺官能化下缀合的ZnO纳米甲族(TSC)的存在下(ZnO @ glu-TSC)以及多种耐药金黄色葡萄球菌中的环丙沙星(CIP)。合成的NPS以紫外线可见光谱,X射线衍射图谱和透射电子显微镜特征。用于确定临床菌株的流出介导的多药抗性表型。然后,使用定量实时PCR(QPCR)评估菌株中菌株中的菌株中的EPG的表达,包括NORA,NORB,NORC和TET38,并进行CIP评价。根据结果​​,抗CIP的菌株显示最小抑制浓度(MIC)值,范围为256至1,024μg/ ml,而ZnO @ glu-TSC NPS显示麦克风,对细菌菌株的8-256μg/ mL显示出来,与CIP相比,表明与CIP相比,NPS(2-8倍)的抗菌活性较强。 ZnO @ glu-TSC NPS分别显示出良好的细菌抑制电位,其平均抑制区域为11,15和20mm,分别为50,100和150μg/ ml。此外,同时使用ZnO @ glu-TSC NPS(1/2麦克风)与CIP(1/2麦克风)的组合显着降低了Nora,Norb,Norc和Tet38的表达5.4-,3.8-,2.1-,单独的CIP分别分别为3.4倍。因此,ZnO @ Glu-TSC NPS具有它们有效的抗微生物效应可以用作针对金黄色葡萄球菌的抗微生物剂,用于预防和/或治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号